CD8A and neoplasm: These highly reproducible imaging results (Supplementary Fig. 15) indicated OVA antigen-specific CD8+ CTLs accumulation in the tumour in response to pErNP–OVA–CpG B vaccination, which correlated well with effective cancer cell killing by CTLs and tumour shrinking.